Table 1.
Reference | Liakopoulou [11] |
Vanderheiden, 1970 [12] |
Vanderheiden, 1979 [13] |
Holmes [14] |
Lin [1] | Stepchenkova [18] |
Herting [15, 19] |
---|---|---|---|---|---|---|---|
Protein source |
Hemolysate | Partially purified from hemolysate |
Purified from hemolysate |
Hemolysate | Purified from E. coli |
Purified from E. coli |
Purified from E. coli |
Km | 1 × 10−4 M | 6 × 10−4 M | 1.3 × 10−4 M | 7 × 10−5 M | 5.1 × 10−4 M | 4.0 × 10−4 M | 3.25 ×10−5 M |
Vmax | N/A | N/A | 1.2 × 10−9 M/min | N/A | 1520 µmol/(min·mg) | N/A | N/A |
kcat | N/A | N/A | N/A | N/A | 580 s−1 | 91 s−1 | 79.6 s−1 |
pH optimum | 7.5 | 8.5 (9.5 with DTT) | 8.6 in Tris-HCl 9.6 in glycine | N/A | 10.0 | N/A | N/A |
Mg2+ optimum | 50 mM | 50 mM | 100 mM | 60 mM | 30 – 100 mM | N/A | N/A |
Substrate inhibition | No | Yes | Slight | No | Yes | Yes | Yes |
Reducing agent activation | N/A | Yes | No | Yes | Yes | N/A | N/A |
The substrate was ITP in all cases except for Herting, where dITP was used.